Market Overview

UPDATE: Wunderlich Initiates Coverage on DexCom at Buy


According to Wunderlich Securities, DexCom (NASDAQ: DXCM) coverage is initiated at Buy.

Wunderlich Securities said that it is initiating coverage of DexCom, Inc. (DXCM) with a Buy rating and $12 target. “We believe growing visibility on the Gen4 approval process will allow DXCM shares to reach, and possibly exceed, our $12 price target over the next 12 months.”

DexCom closed yesterday at $8.54.

Posted-In: Wunderlich SecuritiesAnalyst Color Initiation Analyst Ratings


Related Articles (DXCM)

View Comments and Join the Discussion!